FRAMINGHAM, MASS – 04 June 2018 – SCIEX, a global leader in life science analytical technologies, has announced today that it will highlight a suite of recent innovations for streamlining biotherapeutics research and development, as well as its latest technologies for delivering accessible, high performance clinical diagnostics, at ASMS 2018. These developments have been optimized... Read more
DENVER, June 4, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Helmer Scientific, a leading provider of integrated solutions to safeguard temperature-sensitive medications, today announced a collaboration to introduce an industry-first, medical-grade refrigerated solution integrated with an automated dispensing system to provide clinicians secure, single line-item access... Read more
Basel, 03 June 2018 Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Further data demonstrate polatuzumab vedotin’s clinical efficacy across a range of diffuse large B-cell lymphoma subgroups Additional results from the randomised phase III MURANO study support fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan... Read more
International Childhood Oncology Network to Host Inaugural Meeting at Annual ASCO Conference Network of academic and clinical researchers converge to advance pediatric cancer research CARLSBAD, Calif., June 1, 2018 /PRNewswire/ — The International Childhood Oncology Network (ICON) will host its inaugural meeting at the annual American Society of Clinical Oncology (ASCO) conference in Chicago June... Read more
Milwaukee, Wis – June 1, 2018 – With 25 percent of the Healthcare Technology Management (HTM) population expected to retire over the next 10 years, hospitals and healthcare systems face an increasing challenge to train the next generation of professionals safely, affordably and efficiently. At AAMI 2018, GE Healthcare is introducing interactive, customizable training options... Read more
Basel, 01 June 2018 Roche to present data for TECENTRIQ (atezolizumab) from across its genitourinary and gastrointestinal cancer immunotherapy programme at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting The data to be presented further demonstrate potential of TECENTRIQ and Avastin combination in renal cell carcinoma, a type of kidney cancer, and hepatocellular... Read more
● Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug Administration ● Announces partnership with Freenome to accelerate companion diagnostics development in immuno-oncology by combining industry-leading artificial intelligence with QIAGEN’s Sample to Insight solutions ● Showcases QIAGEN’s NGS technologies, including... Read more
Cell and Gene Therapy Catapult contracts VWR for its laboratory consumable needs RADNOR, Pennsylvania, May 24, 2018 /PRNewswire/ — VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and a leading global provider of product and service solutions to laboratory and production customers, has been named the sole supplier of laboratory consumable products for Cell and... Read more
The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics Germantown, Maryland, and Hilden, Germany, May 22, 2018 – QIAGEN today welcomed the First Edition of the World Health Organization’s (WHO) Essential Diagnostics List, which endorses the use of interferon gamma release assays (IGRAs) for the diagnosis of latent TB... Read more
Germantown, Maryland, and Hilden, Germany, May 22, 2018 – QIAGEN today welcomed the First Edition of the World Health Organization’s (WHO) Essential Diagnostics List, which endorses the use of interferon gamma release assays (IGRAs) for the diagnosis of latent TB infection. The inclusion on the list comes as the WHO and other organizations like the... Read more